Enzyme Linked Immunosorbent Assay (ELISA) News and Research

RSS

New biosensor test system developed for accurate measurements of protein molecule concentration in blood

Researchers from the General Physics Institute of the Russian Academy of Sciences and Moscow Institute of Physics and Technology have developed a new biosensor test system based on magnetic nanoparticles.

4 Feb 2016

ProteinSimple expands Simple Plex immunoassay offering with launch of new single analyte cartridge

ProteinSimple announced today an expansion of the Simple Plex immunoassay offering by launching a new single analyte cartridge for the analysis of 72 samples at once. This new cartridge enables Simple Plex users to run 72 samples in an hour with triplicate results. It is powered by R&D Systems reagents, the expert in immunoassays.

From ProteinSimple 29 Jan 2016

Best management unclear for patients needing carotid revascularisation

Research highlights the vulnerability of patients with symptomatic carotid stenosis to stroke while awaiting revascularisation.

19 Jan 2016

Small volumes of biological liquid waste easily aspirated

VACUSIP is an out-of-the-box solution. Simply connect the collection bottle to the built-in pump and choose the aspiration adapter matching your application. Operation is straight forward – switch the unit on and regulate the vacuum by applying pressure on the autoclavable hand adapter.

From INTEGRA Biosciences 14 Jan 2016

Easy aspiration of small volumes of biological liquid waste

VACUSIP is a portable benchtop vacuum aspiration system from INTEGRA that you can place wherever you need it. Besides increased mobility, the battery version of the VACUSIP allows you to keep the workspace clean and organized, making it ideal for the use in a Class II safety cabinet.

From INTEGRA Biosciences 11 Jan 2016

EKF biomarker identifies likely development of Diabetic Nephropathy

EKF, announces new data presented in support of soluble Tumour Necrosis Factor Receptor 1 as a biomarker to predict progression of Diabetic Nephropathy.

From EKF Diagnostics 2 Dec 2015

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

For about the last 25 years, the cardiology group here have been developing a platform technology for both the diagnosis and treatment of atherosclerosis.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 28 Oct 2015

Commonwealth Lab expands access to new IBS test with national agreement with Quest

Commonwealth Laboratories, LLC ("Commonwealth") announced today that it has formed an agreement with Quest Diagnostics ("Quest") that will expand the availability of IBSchek™, a new laboratory developed blood test designed to help physicians quickly and reliably diagnose Irritable Bowel Syndrome (IBS).

From Quest Diagnostics 15 Oct 2015

VolitionRx's NuQ blood test receives CE Mark approval for detection of colorectal cancer

VolitionRx Limited today announced the Company's first CE Mark for its blood-based diagnostic assay, NuQ X001S, for detection of colorectal cancer. The NuQ test utilizes the Company's proprietary Nucleosomics technology platform, which identifies and analyses fragments of chromosomes, called nucleosomes, circulating within the blood for the presence of epigenetic cancer signals.

22 Sep 2015

Qualitative RPCI study evaluates attitudes toward smoking cessation in Northern Appalachia

Significant differences in attitudes toward smoking cessation are reported between two generations of smokers in Northern Appalachia in new research from Roswell Park Cancer Institute.

14 Sep 2015

New nanozyme test can help curb Ebola spread in western Africa

A new Ebola test that uses magnetic nanoparticles could help curb the spread of the disease in western Africa. Research published in Biosensors and Bioelectronics shows that the new test is 100 times more sensitive than the current test, and easier to use. Because of this, the new test makes it easier and cheaper to diagnose cases, enabling healthcare workers to isolate patients and prevent the spread of Ebola.

10 Sep 2015

UCLA study questions value of BRCA genetic testing in general population

Women who are carriers of mutated BRCA genes are known to have a significantly higher risk for developing breast and ovarian cancers than those who don't have the mutations.

4 Sep 2015

RPCI researchers create outreach effort to improve public's participation in biomedical research

Roswell Park Cancer Institute researchers, together with input from African-American community leaders in Buffalo, have created an outreach effort that provides racial/ethnic minority and medically underserved communities with educational programs regarding the public's participation in biomedical research. The program is the basis of a recent study published by a team of local collaborators.

18 Aug 2015

New study explores impact of climate change on human health

Researchers at Columbia University's National Center for Disaster Preparedness and the University of Washington have published a new study focused on the public health implications of climate change. The article explores climate change impacts on human health in the U.S. Gulf Coast and has implications for this and other coastal regions that are particularly vulnerable to climate change.

14 Aug 2015

DigiPath Labs, Romer Labs to validate kit-based assays for food-borne pathogen, mycotoxin testing for cannabis

DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc., is combining efforts with True North Laboratory of Ann Arbor, Michigan, and Romer Labs, a leading global supplier of diagnostic solutions for food-borne pathogens, to investigate the applicability of utilizing Romer Labs' rapid diagnostic test kits to screen for food-borne pathogens and quantify mycotoxins present in cannabis.

28 Jul 2015

Corgenix Medical to present several scientific abstracts at 2015 AACC Clinical Lab Expo

Corgenix Medical Corporation, the U.S. - based operation of ORGENTEC Diagnostika, is presenting several scientific abstracts at the 2015 American Association for Clinical Chemistry Clinical Lab Expo in Atlanta. Three abstracts involve the ReEBOV Ebola rapid diagnostic test (RDT) with a fourth abstract involving the AtherOx™ Assay for assessing heart disease risk.

25 Jul 2015

Bay Area Lyme Foundation announces winners of 2015 Emerging Leader Award

Bay Area Lyme Foundation, the leading national nonprofit funder of innovative Lyme disease research, today announced that the winners of its 2015 Emerging Leader Award, are collaborators Nira Pollock, MD, PhD, and John Branda, MD.

10 Jun 2015

Commonwealth announces availability of new ELISA-based blood test to quickly and reliably diagnose IBS

Commonwealth Laboratories, Inc. announced today the availability of IBSchek, a new blood test designed to help physicians quickly and reliably diagnose Irritable Bowel Syndrome (IBS).

15 May 2015

First CE marked FGF23 ELISA assay launched at Biomedica Immunoassays

The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically detects both intact and C-terminal fragments of FGF23 in human serum and plasma. The FGF23 ELISA assay complements the existing Biomedica assays directed against chronic kidney disease - mineral and bone disorder (CKD-MBD) in a growing collection.

24 Apr 2015

New analysis of medieval cesspit in Jerusalem provides window into spread of infectious diseases

A new analysis of a medieval cesspit in the Christian quarter of the old city of Jerusalem has revealed the presence of a number of ancient parasite eggs, providing a window into the nature and spread of infectious diseases in the Middle East during the 15th century.

23 Mar 2015